CONSOLIDATED BALANCE SHEETS - USD ($)	Aug. 31, 2025	Aug. 31, 2024
Current
Cash	$ 1,802,123	$ 6,499,885
Short-term investments	143,267	0
Marketable securities	22,093	55,807
Accounts receivable	368,358	154,477
Prepaid expenses and other current assets	1,132,504	1,187,817
Total Current Assets	3,468,345	7,897,986
Non-current assets, net
Long-term receivables	64,013	63,575
Right of use assets	106,816	134,843
Intellectual property, net	307,818	516,676
Property & equipment, net	228,129	254,709
Total Non-current Assets	706,776	969,803
TOTAL ASSETS	4,175,121	8,867,789
Current Liabilities
Accounts payable and accrued liabilities	1,463,046	1,066,409
Deferred revenue	0	4,963
Lease liability, current	30,417	28,047
Total Current Liabilities	1,493,463	1,099,419
Lease liabilities - non-current	78,903	109,319
TOTAL LIABILITIES	1,572,366	1,208,738
Stockholders' Equity
Share Capital Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Common shares issued and outstanding: 19,559,179 and 15,810,205 at August 31, 2025 and August 31, 2024, respectively	19,559	15,810
Additional paid-in capital	66,501,086	59,599,178
Accumulated Deficit	(63,460,613)	(51,558,772)
Accumulated other comprehensive loss	(70,335)	(19,816)
Equity attributable to shareholders of Lexaria	2,989,697	8,036,400
Non-controlling Interest	(386,942)	(377,349)
Total Stockholders' Equity	2,602,755	7,659,051
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 4,175,121	$ 8,867,789